After a two-year clinical trial measuring the possible effectiveness of iberdomide (solely, no other drugs) on high-risk smoldering multiple myeloma, my MRD measurements dropped from 273,088 clonal cells down to 692, which of course is great. Yet it's not as close to zero as I was hoping for. Part of the trial's intent was to see if iberdomide could be effective in arresting high-risk SMM's possible progression to MM, but could there possibly be another trial that seeks to drive that 692 down to even less? Feels like with these great results, there might also be a way to prevent MM potential (in essence, perhaps a potential 'cure'?). My team at Emory has been great but they are not aware of any clinical trial that would attempt to further reduce the clonal cell count. Anyone here, especially other providers/clinics, know of anything? Thanks.

What are the advanced symptoms and self care options?

We’d love for you to share your thoughts on the next question!

I apologize in advance for this long post but I heard a question raised by a patient during the recent 2025 Medicare update/changes presentation given by Healthtree and wanted to share what I know about Revlimed coverage in 2025 Medicare Part D plans. As many of you may know, the brand Revlimed has been removed from many (most?) Medicare D plan formularies because a generic (Lenalidomide) is available. I don't see any plan which is covering Revlimed in 2025 -at least not in my geographic area. They are covering Lenalidomide. The issue is that there are exclusivity patents and availability challenges. The exclusivity patent for Revlimed's use for MM maintenance after ASCT expired 2/22/24, however, Lenalidomide is just not available in my state. Small shipments are received sporadically from time to time. The market doesn't have enough Lenalidomide so this is a challenge nation-wide. In 2024, I had my January denial overturned and an exception was granted by the plan for 2024 because they had just removed Revlimed from their formulary in December (after I selected the plan). I argued successfully that this was unfair. This won't work in 2025 since I have no choice than to accept a plan which clearly states Revlimed is not covered. Note: Health plans will update their formularies throughout the year so one month a drug can be covered and the next it is not (or vise versa). This is so unfair to patients! I called the pharmacist this morning to ask about this (I can't afford to pay the $360,000 for Revlimed out-of pocket next year). Their process is to do a pre-authorization for patients. They have been successful in getting Medicare D plans to cover Revlimed by exception. For those plans which still refuse to cover it, they save any Lenalidomide they receive for these patients. Some plans are easier to deal with than others (she is prohibited in sharing this information as to not steer me to a particular plan). Here is information I pulled off of the Medicare web site: "For formulary exceptions, the prescriber's supporting statement must indicate that the non-formulary drug is necessary for treating an enrollee's condition because all covered Part D drugs on any tier would not be as effective or would have adverse effects, the number of doses under a dose restriction has been or is likely to be less effective, or the alternative(s) listed on the formulary or required to be used in accordance with step therapy has(have) been or is(are) likely to be less effective or have adverse effects." The pharmacist at my facility states that potentially they could have more Lenalidomide available in 2025. They are not sure given dependence on just a couple of suppliers. This is what I understand. I hope this information is helpful. Please check with your pharmacy/provider to understand their process for getting Revlimed covered if Lenalidomide is not available in your area.

Can anyone reco a myeloma specialist in Baltimore? My father was just diagnosed, unfortunately VERY late stage with hip bone tumor that already metastasized to other areas. Local U of MD hospital wants to send him to UofMd Baltimore oncology dept. Thanks

Did anyone get a medical ID bracelet or necklace for their SCT? Some sites (Mayo, Sloan Kettering) say it's important, but my nurse said she'd never heard of it.

Aloha my fellow comrades 🌺. I am contemplating having Car T at UCSF. I am relapsed refractory with having had at least 6 lines of therapy. Diagnosed in 2020. I am looking to hear others experiences with their journey and time to relapse. Appreciate realness , thanks

My husband has multiple myeloma, has plasmacytomas that were radiated prior to chemo and SCT. He had a very good result, no detection of active myeloma for a little under two years, is on Lena as maintenance treatment. His MProtein has now started to climb, doubling in the last two months. We have been reading up on diet and note a few articles on caffein and a potential influence on bone marrow, does anyone have any info on this? He is a moderate coffee drinker, about 2 cups a day. Thank you

Hi I have smoldering myeloma IGA for about a year and before that had MGUS. I am being tested every three months and my results increase slightly with each test but I am still in low risk. I would like to know from others experience whether your test progressed at the same level each time or was there a sudden increase out of the blue.